Company intelligence / Profile preview

Stony Point Life Sciences Consulting

New York City / greater NY area, New York, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Stony Point Life Sciences Consulting is an active life sciences consultancy focused on drug development across a wide range of therapeutic areas. The firm provides strategic and operational guidance to pharmaceutical and biotechnology companies. It is led by experienced industry professionals including Cara Cassino (New York) and Dr. Ross Allen Grossman (President), who has extensive experience in human resources leadership within major pharma/biotech organizations. No proprietary clinical results or programs are associated with the company itself.

Industry: Consulting

Beyond the preview

Go deeper on Stony Point Life Sciences Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stony Point Life Sciences Consulting.

Explore the full profile